• Home
  • Who We Are
  • Leadership
  • Our Story
  • Invest
    • Micro Investment
    • Large-Scale Investment
  • Contact Us
  • News
  • More
    • Home
    • Who We Are
    • Leadership
    • Our Story
    • Invest
      • Micro Investment
      • Large-Scale Investment
    • Contact Us
    • News
  • Home
  • Who We Are
  • Leadership
  • Our Story
  • Invest
    • Micro Investment
    • Large-Scale Investment
  • Contact Us
  • News

OUR FOUNDER'S STORY

Doug Oliver speaking at a Bipartisan Policy Center event in Washington, DC.

At age 53, Doug Oliver had already lived for over a decade with Macular Degeneration, an incurable retinal disease that robbed him of his sight.

But in 2015, all that changed.


That’s when Doug received a pioneering stem cell therapy that restored his vision, allowing allowing him to once again see faces, read books, drive a car.It was an outcome so extraordinary that news about it spread around the globe. 


His story soon made its way to Washington, DC, and it wasn’t long before lawmakers reached out to him asking for help in changing federal policy. This empowered Doug with an urgency to offer help crafting what became the 21st Century Cures Act, expanding access to regenerative care for millions.


Now, Doug and his team have founded Sanaregen™ Vision Therapeutics to turn hope to reality with cell therapies that effectively treat retinal disease.



Copyright © 2025 | Sanaregen™ Vision Therapeutics, Inc. | All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept